Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18880921 | 0.89 | TDP1 (0.43) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL15267779 | 0.84 | TDP1 (0.35) | LMNAL3MBTL1TDP1PDE4ATSHR | |
| SCHEMBL30473268 | 0.83 | TDP1 (0.34) | LMNAL3MBTL1TDP1PDE4ATSHR | |
| SCHEMBL7681610 | 0.81 | TDP1 (0.33) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL28404010 | 0.80 | LMNA (0.43) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL2223103 | 0.80 | PAX8 (0.40) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL16144869 | 0.80 | TDP1 (0.36) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL1320767 | 0.80 | TDP1 (0.66) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL9617278 | 0.80 | PAX8 (0.40) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL1182040 | 0.80 | PAX8 (0.40) | LMNAL3MBTL1TDP1PDE4AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544085-B2 | Oils having antibacterial activity | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2020-01-28 | — | — | US | disclosed |
| US-20180201571-A1 | OILS HAVING ANTIBACTERIAL ACTIVITY | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2018-07-19 | — | — | US | disclosed |
| US-9950986-B2 | Oils having antibacterial activity | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2018-04-24 | — | — | US | disclosed |
| US-20170050916-A1 | NOVEL OILS HAVING ANTIBACTERIAL ACTIVITY | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2017-02-23 | — | — | US | disclosed |
| WO-2015142736-A1 | NOVEL OILS HAVING ANTIBACTERIAL ACTIVITY | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2015-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544085-B2 | Oils having antibacterial activity | AGL, DAGLA, DAGLB | LMNA 755/4885L3MBTL1 49/4885TDP1 1157/4885 |
| US-20180201571-A1 | OILS HAVING ANTIBACTERIAL ACTIVITY | AGL, DAGLA, DAGLB | LMNA 755/4885L3MBTL1 49/4885TDP1 1157/4885 |
| US-20170050916-A1 | NOVEL OILS HAVING ANTIBACTERIAL ACTIVITY | DAGLA, DAGLB, AGL | LMNA 830/4885L3MBTL1 41/4885TDP1 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.